Cargando…
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
Docetaxel, a new semisynthetic taxoid that has demonstrated promising activity as an antineoplastic agent, was administered in combination with cisplatin to 63 patients in a dose-escalating study. As both drugs were known to be potentially neurotoxic, peripheral neurotoxicity was prospectively asses...
Autores principales: | Hilkens, P. H., Pronk, L. C., Verweij, J., Vecht, C. J., van Putten, W. L., van den Bent, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063386/ https://www.ncbi.nlm.nih.gov/pubmed/9020489 |
Ejemplares similares
-
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
por: Oh, S C, et al.
Publicado: (2005) -
Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004) -
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
por: Pronk, L C, et al.
Publicado: (2000) -
Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report
por: Moloney, Thomas P, et al.
Publicado: (2014) -
Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms
por: Tofthagen*, Cindy, et al.
Publicado: (2013)